Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Peladawnon Nov 07, 2024 2:53pm
73 Views
Post# 36301639

RE:1 year on

RE:1 year onHere's a post from Quentin on Oct 3rd....

Post by Quentin30on Oct 03, 2024 5:30pm
170 Views 
Post# 36252399

1 dollar

well, it's time tomorrow... has to get back over a dollar to avoid that delisting letter...  this is so orchestrated... but well done on those of you who chose to jump back in at the lows in anticpation of this rise... up another 8 cents tomorrow...

then back down again on monday...

The share price was about .85, that day I believe....the very next day it went to 1.40..........and here's ol' quenty, still posting away, still spreadin it, advising all to get out before the company "implodes"...lol....

Hey Quenty....like others have said on here, you had better get on the phone right away and warn Roche, and the other big pharmas that have spent a lot of money collaborating with Oncy on trials, oh and also the FDA that they're risking their time on Oncy since you, alone, out of all those PHD's, specialists and scientists have figured out that Oncy is a dud!.....just think of the good you could do for humanity!

<< Previous
Bullboard Posts
Next >>